icon-folder.gif   Conference Reports for NATAP  
 
  AASLD/EASL Special Conference
on Hepatitis C
New York City, New York
September 12 - 13
Back grey_arrow_rt.gif
 
 
 
Changes in Intrahepatic, Endogenous Interferon Expression in Chronic HCV, Genotype-1 Patients Treated with Interferon-free, Ribavirin-Free DAA Regimens
 
 
  Reported by Jules Levin
NY AASLD/EASL Special Conference Sept 2014
 
Eric G. Meissner1,2, Anita Kohli1,3, Amy Nelson1, Zayani Sims4, John McHutchison5, Henry Masur4, Shyam Kottilil1,6.
1. Laboratory of Immunoregulation/NIAID/NIH, Bethesda, MD.
2. Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC.
3. Clinical Research Directorate/CMRP, SAIC-Frederick, Inc., Frederick, MD.
4. Critical Care Medicine Department/NIH, Bethesda, MD.
5. Gilead Sciences, Foster City, CA.
6. Institute of Human Virology, University of Maryland Medical School, Baltimore, MD.

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif